Related Experiment Video
Updated: Dec 19, 2025
Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
Published on: August 8, 2022
Drug-loading three-dimensional scaffolds based on hydroxyapatite-sodium alginate for bone regeneration
Tingting Liang1, Jingwen Wu1, Fuyao Li1
1Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, China.
This study explores the use of three-dimensional printed scaffolds made from hydroxyapatite and sodium alginate for bone regeneration. The scaffolds were loaded with naringin or calcitonin-gene-related peptide to enhance osteogenesis. Using scanning electron microscopy and cell tests, the researchers found that scaffolds with these drugs showed better cell proliferation and mineralization than the control scaffolds. Animal experiments supported these findings. The study suggests that these drug-loaded scaffolds may be useful for tissue engineering applications. The authors conclude that the HA/SA scaffold is biocompatible and could be a promising material for bone regeneration.
Area of Science:
- Tissue engineering in regenerative medicine
- Biomaterials in orthopedic surgery
Background:
Bone regeneration remains a clinical challenge due to limited scaffold options. Prior research has shown that osteoprogenitor cells and osteogenic factors are essential for tissue engineering. However, scaffold materials often face limitations in biocompatibility and source availability. This gap motivated the development of new composite scaffolds. No prior work had resolved the issue of drug-loading in hydroxyapatite-based scaffolds. The need for osteoconductive materials persists in clinical settings. Scaffolds must support cell proliferation and differentiation. This study addresses the lack of functionalized scaffolds for bone regeneration.
Purpose Of The Study:
The aim was to develop a drug-loaded scaffold for bone regeneration. Three-dimensional printing was used to fabricate hydroxyapatite-sodium alginate scaffolds. Naringin and calcitonin-gene-related peptide were selected as osteogenic agents. The specific problem addressed was limited scaffold biocompatibility. The motivation was to improve osteogenesis through drug incorporation. Scaffold properties were evaluated using cell and animal models. The study sought to compare scaffold osteogenic potential. This work contributes to advancing tissue engineering strategies.
Main Methods:
Three-dimensional printing was used to create HA/SA scaffolds. Naringin and CGRP were incorporated into the scaffold matrix. Scanning electron microscopy assessed scaffold morphology. Cell counting kit-8 testing measured cell viability. Alkaline phosphatase staining evaluated osteogenic differentiation. Alizarin red-D staining detected mineralization. Animal experiments confirmed in vitro findings. Physicochemical properties were compared across scaffold types.
Main Results:
HA/SA scaffolds showed similar physicochemical properties in all groups. HA/SA/NG scaffolds displayed enhanced osteogenesis compared to controls. HA/SA/CGRP scaffolds also showed improved osteogenesis. Cell viability was higher in drug-loaded scaffolds. Alkaline phosphatase activity was elevated in NG and CGRP groups. Alizarin red-D staining revealed increased mineralization. Animal experiments supported in vitro results. These findings suggest drug incorporation improves scaffold performance.
Conclusions:
The HA/SA scaffold is a biocompatible material suitable for bone regeneration. NG and CGRP doping improved osteogenic potential according to the authors. The study suggests that drug-loaded scaffolds may enhance cell proliferation. The findings propose that HA/SA scaffolds could be used in clinical settings. The authors state that NG and CGRP contribute to better differentiation. The study does not claim that these scaffolds are essential for all applications. The results suggest potential for further scaffold development. The authors conclude that drug incorporation may improve tissue engineering outcomes.
Frequently Asked Questions
The scaffolds with naringin and CGRP showed better osteogenesis than the control HA/SA scaffolds.
Scanning electron microscopy and cell counting kit-8 testing were used to evaluate scaffold properties.
Three-dimensional printing allows precise scaffold design, while HA/SA provides biocompatible and osteoconductive properties.
Alizarin red-D staining detects mineralization, indicating osteogenic differentiation of mesenchymal stem cells.
Cell viability was higher in HA/SA scaffolds loaded with naringin or CGRP compared to the control.
The authors propose that HA/SA scaffolds could be a biocompatible material with potential for bone regeneration.
